Friday, July 10, 2026

pharma · Hypertension · Breast Neoplasms

Pfizer

Pfizer is a pharma organization headquartered in PARIS, FR. Primary therapeutic focus areas include Hypertension, Breast Neoplasms, Complicated Intra-abdominal Infection, Non-Small Cell Lung Cancer, Arthritis, Rheumatoid

New York 10017, US HQ
103,316 Employees
EMA registrant Type
Company details
Clinical program

MenACWY-TT

Phase 3 · mab · Meningococcal ACWY Disease

MenACWY-TT for Meningococcal ACWY Disease is a Phase 3 program (mab) at Pfizer with 1 ClinicalTrials.gov record(s).

← All Pfizer projects Phase 3 mab completed

Internal code MENACWY-TT-101

Full intelligence profile for this program is being prepared.

At a glance

Sponsor
Pfizer
Phase
Phase 3
Modality
mab
Indication
Meningococcal ACWY Disease
Status
completed
Trials
1

Clinical trials